These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25876206)

  • 1. We should prohibit warfarin in idiopathic pulmonary fibrosis.
    Alagha K; Secq V; Pahus L; Sofalvi T; Palot A; Bourdin A; Chanez P
    Am J Respir Crit Care Med; 2015 Apr; 191(8):958-60. PubMed ID: 25876206
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant Therapy in Idiopathic Pulmonary Fibrosis and Its Potential Effects on Pathogenesis.
    Janssen R
    Am J Respir Crit Care Med; 2016 Mar; 193(6):700-1. PubMed ID: 26977973
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels.
    Lin C; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1257-9. PubMed ID: 26568245
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels.
    Alagha K; Bourdin A; Chanez P
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1259-60. PubMed ID: 26568246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Time to revise guidelines concerning anticoagulants in atrial fibrillation].
    Terént A
    Lakartidningen; 2002 Oct; 99(44):4375-7. PubMed ID: 12469584
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin therapy for elderly persons with atrial fibrillation.
    Ackermann RJ
    Am Fam Physician; 1998 Jul; 58(1):45-6, 48-9. PubMed ID: 9672429
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
    Cowan A; Hylek EM
    J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 9. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
    Cheng HY
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
    [No Abstract]   [Full Text] [Related]  

  • 10. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical impact and therapeutic implications of cerebral microbleeds in patients on warfarin.
    Ding D
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2553-4. PubMed ID: 24139629
    [No Abstract]   [Full Text] [Related]  

  • 12. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 13. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 15. At last, a RE-LYable alternative to warfarin for atrial fibrillation.
    Hankey GJ
    Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].
    Steurer J
    Praxis (Bern 1994); 2014 Jun; 103(13):785-6. PubMed ID: 24938162
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation in elderly persons: a call for wider use.
    Portnoi VA
    Am Fam Physician; 1998 Jul; 58(1):39-40, 42. PubMed ID: 9672428
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistence with therapy among patients treated with warfarin for atrial fibrillation.
    Gomes T; Mamdani MM; Holbrook AM; Paterson JM; Juurlink DN
    Arch Intern Med; 2012 Nov; 172(21):1687-9. PubMed ID: 23090098
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
    Lane DA; Lip GY
    Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.